Yang et al. (87) demonstrated that cryptotanshinone lowers testosterone levels in HCG and Ins-induced PCOS rat models by inhibiting the HMGB1/TLR4/NF-κB signaling pathway, ultimately improving reproductive function. This evidence concerns the gene NFKB1 and polycystic ovary syndrome.